No image published for this recall

No image published for this recall

JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.

Official notice

21 Jun 2023

Last checked

21 Jun 2023

Critical riskHealth Canada

An official Health Canada notice concerns JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.. Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose Published 2023-06-21.

What to do now

Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37. 5 mg capsules to make sure it contains 37. 5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules. If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal. Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache. Contact JAMP Pharma Corporation by email at alewicki@jamppharma. Com if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.

Recall number

73862

Official notice

2023-06-21

The hazard

Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

73862

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Brand: Jamp Venlafaxine Xr 37.5 MG Sold To Pharmacies In Bottles Of 100 Capsules For Dispensing.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

App estimate

critical

Recall details

Recall number

73862

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 21 Jun 2023. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.